LUMBALGINE

This brand name is authorized in France.

Active ingredients

The drug LUMBALGINE contains a combination of these active pharmaceutical ingredients (APIs):

1	Glycol salicylate UNII 3I1VBB7AXH - GLYCOL SALICYLATE
	Read more about Glycol salicylate
2	Camphora UNII 5TJD82A1ET - CAMPHOR (SYNTHETIC)
	Read more about Camphora
3	Nicotinic acid UNII S497LCF9C9 - BENZYL NICOTINATE
	Niacin (nicotinic acid) is an essential B complex Vitamin (B3), whose deficiency results in the clinical syndrome known as pellagra. Nicotinamide (niacinamide), the active ingredient, is the physiologically active form of niacin and is the chemical form of Vitamin B3 found in virtually all multivitamin products. Though nicotinic acid and nicotinamide are so closely related chemically, they differ somewhat in pharmacological properties.
	Read more about Nicotinic acid
4	Menthol UNII BZ1R15MTK7 - LEVOMENTHOL
	Read more about Menthol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AC	Preparations with salicylic acid derivatives	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	64590108